"Current Valuation is Disconnected From Future Growth Outlook" - William Blair Reiterates Collegium Pharmaceutical (COLL) at Outperform Apr 5, 2022 12:28PM
Collegium Pharmaceutical (COLL) Is the Prime Beneficiary of the Purdue Bankruptcy - William Blair Sep 17, 2019 07:05AM
Collegium to Present at Upcoming Investor Conferences May 29, 2019 08:00AM
Collegium to Present at Upcoming Investor Conferences May 29, 2019 08:00AM
Collegium to Present at Upcoming Investor Conferences May 30, 2018 04:01PM


May 30, 2018 04:01PM Collegium to Present at Upcoming Investor Conferences
Feb 12, 2018 11:35AM Purdue Oxycontin News a 'Clear Positive' for Collegium Pharmaceutical (COLL) - William Blair
Nov 9, 2017 09:50AM Collegium (COLL) Xtampza ER Sales More than Double Expectations - William Blair
May 23, 2017 07:52AM Collegium to Present at Upcoming Investor Conferences
Nov 29, 2016 07:30AM Collegium Announces Underwriters’ Exercise of Option to Purchase Additional Shares
Oct 26, 2016 09:02AM Collegium Pharma (COLL) Prices 5M Share Stock Offering for Proceeds of $80M
Oct 26, 2016 09:00AM Collegium Prices Public Offering of $80 million of Common Stock
Jun 2, 2016 10:36AM Collegium to Present at Jefferies and William Blair Conferences
Feb 19, 2016 07:48AM William Blair Starts Collegium Pharmaceutical (COLL) at Outperform
Jan 8, 2016 06:02AM Collegium Pharma (COLL) Prices 2.75M Common Stock Offering at $20/Share
Jan 8, 2016 06:00AM Collegium Pharmaceutical, Inc. Prices Public Offering of $55.0 Million of Common Stock